Acknowledgements
Cancer
CANCER
Dr. Brana wishes to thank the Instituto de Salud Carlos III (Rio Hortega contract CM15/00255); the Comprehensive Program of Cancer Immunotherapy & Immunology (CAIMI), which was supported by the Banco Bilbao Vizcaya Argentaria Foundation (grant 89/2017); the La Caixa Foundation (LCF/PR/CEO7/50610001); and the Cellex Foundation, which provided research facilities and equipment. Editorial and medical writing support for this manuscript was provided by Tiffany DeSimone, PhD, and Jason Tuffree of Ashfield MedComms, an Inizio Company, and were funded by Incyte Corporation.